These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2069 related articles for article (PubMed ID: 19053527)

  • 1. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry.
    Garbis SD; Tyritzis SI; Roumeliotis T; Zerefos P; Giannopoulou EG; Vlahou A; Kossida S; Diaz J; Vourekas S; Tamvakopoulos C; Pavlakis K; Sanoudou D; Constantinides CA
    J Proteome Res; 2008 Aug; 7(8):3146-58. PubMed ID: 18553995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers.
    Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ
    J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential protein expressions in renal cell carcinoma: new biomarker discovery by mass spectrometry.
    Siu KW; DeSouza LV; Scorilas A; Romaschin AD; Honey RJ; Stewart R; Pace K; Youssef Y; Chow TF; Yousef GM
    J Proteome Res; 2009 Aug; 8(8):3797-807. PubMed ID: 19610612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.
    Whiteaker JR; Zhang H; Zhao L; Wang P; Kelly-Spratt KS; Ivey RG; Piening BD; Feng LC; Kasarda E; Gurley KE; Eng JK; Chodosh LA; Kemp CJ; McIntosh MW; Paulovich AG
    J Proteome Res; 2007 Oct; 6(10):3962-75. PubMed ID: 17711321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation.
    Sarvaiya HA; Yoon JH; Lazar IM
    Rapid Commun Mass Spectrom; 2006; 20(20):3039-55. PubMed ID: 16986208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of biomarkers indicating cellular changes after treatment of neuronal cells with the C3 exoenzyme from Clostridium botulinum using the iTRAQ protocol and LC-MS/MS analysis.
    Muetzelburg MV; Hofmann F; Just I; Pich A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(13):1344-51. PubMed ID: 19109081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples.
    Levin Y; Schwarz E; Wang L; Leweke FM; Bahn S
    J Sep Sci; 2007 Sep; 30(14):2198-203. PubMed ID: 17668910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
    Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
    J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.
    Pawlik TM; Hawke DH; Liu Y; Krishnamurthy S; Fritsche H; Hunt KK; Kuerer HM
    BMC Cancer; 2006 Mar; 6():68. PubMed ID: 16542425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A proteomics study on human breast cancer cell lines by fluorogenic derivatization-liquid chromatography/tandem mass spectrometry.
    Imai K; Ichibangase T; Saitoh R; Hoshikawa Y
    Biomed Chromatogr; 2008 Nov; 22(11):1304-14. PubMed ID: 18821527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry.
    Li DQ; Wang L; Fei F; Hou YF; Luo JM; ; Zeng R; Wu J; Lu JS; Di GH; Ou ZL; Xia QC; Shen ZZ; Shao ZM
    Proteomics; 2006 Jun; 6(11):3352-68. PubMed ID: 16637015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein labeling by iTRAQ: a new tool for quantitative mass spectrometry in proteome research.
    Wiese S; Reidegeld KA; Meyer HE; Warscheid B
    Proteomics; 2007 Feb; 7(3):340-50. PubMed ID: 17177251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative protein profiling by mass spectrometry using label-free proteomics.
    Haqqani AS; Kelly JF; Stanimirovic DB
    Methods Mol Biol; 2008; 439():241-56. PubMed ID: 18370108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers.
    Sardana G; Jung K; Stephan C; Diamandis EP
    J Proteome Res; 2008 Aug; 7(8):3329-38. PubMed ID: 18578523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated serum proteomic approach capable of monitoring the low molecular weight proteome with sequencing of intermediate to large peptides.
    Merrell K; Thulin CD; Esplin MS; Graves SW
    Rapid Commun Mass Spectrom; 2009 Sep; 23(17):2685-96. PubMed ID: 19630037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer.
    DeSouza LV; Romaschin AD; Colgan TJ; Siu KW
    Anal Chem; 2009 May; 81(9):3462-70. PubMed ID: 19323455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
    Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
    J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
    Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
    J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 104.